1-Methylpiperazine → HCID 21254914, compound
Reaction equation
[CH3:1][N:2]1[CH2:7][CH2:6][NH:5][CH2:4][CH2:3]1.[C:8]1([S:14]([C:17]2[C:18]([S:31][CH3:32])=[N:19][N:20]3[C:25](Cl)=[CH:24][C:23]([CH2:27][CH2:28][O:29][CH3:30])=[N:22][C:21]=23)(=[O:16])=[O:15])[CH:13]=[CH:12][CH:11]=[CH:10][CH:9]=1>CN(C=O)C>[C:8]1([S:14]([C:17]2[C:18]([S:31][CH3:32])=[N:19][N:20]3[C:25]([N:5]4[CH2:6][CH2:7][N:2]([CH3:1])[CH2:3][CH2:4]4)=[CH:24][C:23]([CH2:27][CH2:28][O:29][CH3:30])=[N:22][C:21]=23)(=[O:16])=[O:15])[CH:13]=[CH:12][CH:11]=[CH:10][CH:9]=1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
0.5 g (5 mmol) of 1-methyl-piperazine in 3 ml of DMF was added to a solution of 0.45 g (1.13 mmol) of 3-benzenesulphonyl-7-chloro-5-(2-methoxy-ethyl)-2-methylsulphanyl-pyrazolo[1,5-a]pyrimidine in 20 ml of DMF and stirred at RT for 3 hrs. The reaction solution was evaporated, the residue was partitioned between 2N NaOH and CH2Cl2. The aqueous phase was extracted three times with CH2Cl2, the combined organic phases were dried (MgSO4), filtered and evaporated. Subsequent chromatography (silica gel, CH2Cl2/MeOH 12:1) and crystallization from EtOH yielded 0.255 g (67%) of 3-benzenesulphonyl-5-(2-methoxy-ethyl)-7-(4-methyl-piperazin-1-yl)-2-methylsulphanyl-pyrazolo[1,5-a]-pyrimidine as colorless crystals, m.p. 160-161°.
Workup
- customThe reaction solution was evaporated
- customthe residue was partitioned between 2N NaOH and CH2Cl2
- extractionThe aqueous phase was extracted three times with CH2Cl2
- dry with materialthe combined organic phases were dried (MgSO4)
- filtrationfiltered
- customevaporated
- customSubsequent chromatography (silica gel, CH2Cl2/MeOH 12:1) and crystallization from EtOH
Sources & evidence
- ORD record
- ord-5207724e7a934a0983479ef0d10e5be5
- Source dataset
- uspto-grants-2001_02
- Patent number
- US06194410B1
Reaction notes
Loading…